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Abstract 
Objective  
To estimate utilization cost of spontaneous vaginal delivery (SVD) and caesarean delivery (CD) for 
pregnant women with Coronavirus Disease (COVID-19) at the largest teaching hospital in Lagos, the 
pandemic’s epicenter in Nigeria. 
 Methods 
We collected facility-based and household costs of all nine pregnant women with COVID-19 
managed at the hospital. We compared their mean facility-based costs with those paid by pregnant 
women pre-COVID-19, identifying cost-drivers. We also estimated what would have been paid 
without subsidies, testing assumptions with a sensitivity analysis. 
Results 
Total utilization cost ranged from US$494 for SVD with mild COVID-19 to US$4,553 for emergency 
CD with severe COVID-19. Though 32-66% of facility-based cost were subsidized, cost of SVD and CD 
during the pandemic have doubled and tripled respectively compared to those paid pre-COVID. Of 
the facility-based costs, cost of personal protective equipment (PPE) was the major cost-driver 
(50%). Oxygen was the major driver for women with severe COVID-19 (48%). Excluding treatment 
costs for COVID-19, mean facility-based costs were US$228 (SVD) and US$948 (CD). 
Conclusion 
Despite cost exemptions and donations, utilization costs remain prohibitive. Regulation of PPE and 
medical oxygen supply chains and expansion of advocacy for health insurance enrolments are 
needed to minimize catastrophic health expenditure. 
 
INTRODUCTION 
Since its emergence in December 2019, the Coronavirus disease 2019 (COVID-19) has been a major 
disruptor to humanity.[1] By mid-October 2020, there have been over 38 million confirmed cases, 
including over one million deaths globally.[1] This has come on the heels of significant gains in global 
maternal mortality reduction over the past two decades. In 2017, it was estimated that there were 
295,000 maternal deaths worldwide.[2] However, modelled estimates published early in the COVID-
19 pandemic predicted that an 8·3-38·6% increase in maternal deaths should be expected per 
month.[3] Such increments do not bring countries any closer to achieving the global target of 
reducing maternal mortality ratio to 70 per 100,000 live-births.[4] Nigeria alone accounts for 25% of 
the global maternal deaths 
Access to skilled health personnel is critical for reducing these deaths.[5] However, one key barrier 
that limits access as to skilled health personnel is service cost.[2] In Africa, 97% of mothers are 
delivered by spontaneous vaginal delivery (SVD) or caesarean delivery (CD).[6] Guidelines have been 
published on how both SVD and CD should be provided to pregnant women with COVID-19 in 
Nigeria in line with global guidance.[7] However, do the revamped services resulting from the 
guideline come at an additional cost to women? 
The many indirect effects of COVID-19 and the consequences of the lockdown measures 
implemented by many countries,[3] including Nigeria, brings a need to focus on the cost of utilizing 
maternity services during the pandemic. Lagos is the epicenter of the COVID-19 pandemic in Nigeria 
with 20,370 cases and 204 deaths, compared to the national average of 1,644 cases and 30 deaths, 
as of 16th October 2020.[8] The objective of this study was to assess utilization cost of maternity 
services for childbirth amongst pregnant women with COVID-19 in Lagos, Nigeria. 
MATERIALS AND METHODS 
This was a hospital-based cost analysis from the user’s (women’s) perspective. Women were only 
approached after their discharge from the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. 
The inclusion and exclusion criteria used for recruitment is described in Table 1. From the included 
women, we collected data on direct cost components spent within the facility, outside the facility 
(household), opportunity (loss of productivity) costs and any other relevant costs that women 
claimed to have expended for their care. All of these made up total utilization cost. We noted any 
exemptions and donations that reduced the cost paid by women. A detailed review of patient 
financial account records in the hospital was used to capture all facility-based costs. In capturing 
facility-based costs, we separated those related to obstetric care from those for COVID-19 care. For 
comparison, we collected data on the standard SVD and CD facility-based cost for booked and un-
booked pregnant women pre-COVID-19. A pre-tested online tool was administered to women to 
collect household and opportunity costs. We collected data on the monthly income of selfemployed 
women and their caregivers. We only included a pro-rated cost of the typical monthly cost related to 
the number of days that the women spent in hospital. 
All cost data were collected in local currency (Naira (N)). Analysis was conducted in Microsoft Excel 
(Microsoft Corporation, Redmond, United States) following conversion of cost data to United States 
Dollars (US$) as per the mean exchange rate for the year.[9] All costs were presented in US$. To 
synthesize findings, we identified the obstetric (pregnancy complications)[10] and COVID-19 (mild or 
severe)[11] features which may influence utilization costs for each woman. Individual utilization 
costs were summed, and key cost drivers were identified for each case. We estimated the mean and 
median cost of the component and total costs per service (SVD, elective caesarean delivery (ELCD) 
and emergency caesarean delivery (EMCD)). We also estimated how much more women would have 
paid if there were no exemptions or donations. We then conducted a sensitivity analysis to test their 
influence on subsidy valuation. In addition, we compared mean facility-based costs for pregnant 
women with COVID-19 with standard facility-based costs pre-COVID-19. 
Ethical approval was obtained from the Health Research and Ethics Committee, Lagos University 




All nine pregnant women that had laboratory-confirmed COVID-19 and managed in LUTH between 
1st April 2020 and 31st August 2020 were recruited for this study. Their ages ranged from 22 to 40 
years (Median: 33 years). All nine women were married and had attained tertiary education. Six of 
the women were employed, one selfemployed and the remaining two were unemployed. The 
spouses of all nine women were employed. 
Of the nine women, two remained symptomatic while on admission presenting with Acute 
Respiratory Distress Syndrome (ARDS), the other seven were asymptomatic until discharge. Seven 
presented with no obstetric complications during the index pregnancy. For mode of delivery, there 
were eight CDs (Case 1-8). Five cases were done as an elective (Case 1-5), and the other three were 
emergency (Cases 6-8). All CDs were done under spinal anesthesia. Case 9 was the only patient who 
gave birth via SVD. The women spent between 4 and 22 days on admission (Median: 15 days) [Table 
2]. Except for one macerated stillbirth, all mothers and their babies were discharged alive. 
The total utilization (facility-based and household) cost was US$494 for the sole pregnant woman 
who had SVD and mild COVID-19. Total utilization cost for those who gave birth via CD ranged from 
US$914 for a pregnant woman who had uncomplicated ELCD to US$4,553 for one who had EMCD 
and severe COVID-19. Mean total utilization cost across the entire population was US$1,529 
(Standard deviation: US$1,112). When disaggregated, facility-based costs made up the highest 
proportion (67% of the mean total utilization cost) while opportunity cost due to loss of productivity 
of the caregiver made up 30%. Transport, childcare and purchase of other sundry items constituted 
the remaining 3% [Table 2]. 
For facility-based costs, the hospital management exempted all COVID-19 patients from paying the 
service fee, ward admission and feeding, in line with the Federal Government’s directive. In addition, 
laboratory confirmation for COVID-19 by Reverse Transcription Polymerase Chain Reaction test was 
free. With support from government, international agencies, some charities and philanthropists, 
some personnel protective equipment (PPE) were made available to skilled health personnel, at no 
cost to the women. 
For the costs still required, the woman who had SVD paid a total of US$228. Cost of additional PPE 
required for their care was the major cost driver (50%), followed by supplies (20%) and obstetric 
diagnostics (17%). For ELCD, facility-based cost ranged from US$749 to US$1,109, with a median cost 
of US$903. Major cost drivers for ELCD were PPE (50%), medicines (28%), and medical supplies 
(14%). Excluding the cost of additional supplemental oxygen required by women who had severe 
COVID-19 symptoms, EMCD cost from US$719 to US$1,517. The major cost drivers were medicines 
(35%), PPE (32%), and diagnostics (18%). Based on severity of COVID-19 symptoms, cost ranged from 
US$228 for a woman with mild disease and gave birth via SVD to US$2,939 paid by a woman who 
had severe COVID-19 symptoms requiring additional supplemental oxygen extra-operatively while 
on admission. For this latter case (Case 7), medical oxygen required to manage severe COVID-19 
symptoms was the major cost driver (48%), followed by medicines (20%), and supplies (14%) [Table 
2]. 
Cost of SVD for pregnant women with COVID-19 has more than doubled cost paid by a booked 
pregnant woman pre-COVID (US$113). For CD, excluding medical oxygen, the average facility-based 
cost of all eight CD patients (US$984) was about 2.5 times more than what women paid pre-COVID 
(US$384) [Table 2 and Table 3]. 
If there were no exemptions and donations, the pregnant woman with mild COVID-19 who gave 
birth via SVD (Case 9) would have paid US$526 as facility-based costs, meaning she received 57% of 
the facility-based cost as subsidies and donations. Pregnant women with mild COVID-19 requiring CD 
(Case 1-5 and 7) would have paid US$1,767-US$1,960, though their costs were subsidized by 43%-
66%. Those with severe COVID-19 symptoms requiring CD would have paid US$2,181-US$5,088, 
though their costs were subsidized by 42%-65% [Table 4]. Using the most conservative estimates on 
potential cost subsidies being received by the women, facility-based costs were subsidized by 
between 21% and 51% [Table S1]. 
DISCUSSION 
Regarding facility-based costs, we found that pregnant women with COVID-19 are paying as much as 
US$228 for SVD when they have mild COVID-19 and US$2,939 for EMCD when they present with 
severe COVID-19. In a 2020 systematic review, median cost of utilizing SVD across LMICs was US$40 
in a public hospital while CD was US$178 in public hospitals.[12] Thus suggests that COVID-19 
pregnant women are paying six times more for SVD and as much as 16 times more if they have 
severe COVID-19 and require CD.[12] 
It is established that tertiary hospitals like LUTH are significantly more expensive for care compared 
to secondary and primary facilities, mostly because of their specialist expertise.[12] However, the 
standard cost for an un-booked patient managed in LUTH pre-COVID (US$464) is still less than the 
maximum obtainable cost reported for another Nigerian teaching hospital (US$667) in 2013.[13] In 
our study, despite government-mandated cost exemptions on certain cost components and 
donations to support care provision,[14,15] pregnant women with COVID-19 are paying as much as 
two times more for SVD and three times more facility-based costs for CD when compared to the pre-
COVID era. The major cost driver was PPEs. Pre-COVID, most reported that medicines and supplies, 
transport, and lodging were the major cost drivers that women had to tackle to access care.[12] 
However, there is also the emergence of medical oxygen as the major cost driver in the severe cases 
that require long hospital admission. This is despite oxygen being the second most important 
component for COVID-19 care.[16] 
In our study, no woman reported giving any gifts to health workers. With so much caution being 
taken with care of pregnant women with COVID-19, it might be the case that the women are simply 
not giving gifts. However, this is unlikely, as Nigerian pregnant women typically show their 
appreciation of the efforts of health workers in taking care of them by gifting.[13] A more plausible 
explanation may be that the health workers themselves are refusing to receive gifts or tips because 
they want to minimize contact, conscious of the possibility of being infected through the gifting. 
For the other cost components, median transport costs (US$10) reported in our study is higher than 
in Tanzania (US$0.09) but lower than US$51 reported in Bangladesh.[17,18] In our study, 
opportunity costs ranged from US$243 to US$572, while in the literature, adjusted estimates ranging 
from US$3 in Lao PDR for SVD to US$89 for CD in Nepal have been reported.[12] This may be 
because pregnant women with COVID-19 stayed longer on admission, as such, their partners had to 
stay longer away from work. 
There are clear policy implications of our study findings. Pre-COVID-19, providers used some PPE, 
albeit not as many as is now being required. Indeed, demand currently outstrips supply by far, with 
60% of providers reporting insufficient PPE to keep them safe while providing care.[19] With such 
gaps in the PPE supply chain, costs are being passed to women. This increases the risk of 
catastrophic health expenditure. Providers, more so those in LMICs, need to explore innovative ways 
to source PPEs without passing the burden unto pregnant women.[20] There is a case for 
governments to mobilize local PPE production and negotiate with sellers, while offering incentives 
for reduced costs and regulate sell-on costs. New thinking is also needed for oxygen supply. Pre-
COVID-19, there was already concern about oxygen sufficiency in Africa.[16] While approaches such 
as installing oxygen concentrators, enabling private construction of oxygen plants, and use of solar-
powered oxygen delivery are being implemented to boost oxygen supply during the pandemic,[16] 
these costs should not be passed on to pregnant women. 
It should be noted that the women in our study were all educated and they and/or their partners 
were employed, yet, as our results showed, they benefited 32-62% of subsidies in facility-based 
costs. With 40% of the population living below the poverty line,[21] many will not be able to afford 
these increased service utilization of the COVID-19 era, without these donations and exemptions. 
Indeed, there might be a case for a comprehensive fee exemption policy, as was done by a state 
government in Nigeria.[22] However, it is not known how long this can be sustained, with treatment 
of one patient with COVID-19 costing government US$260-US$2,604/day.[23] Likewise, how long 
can donations last? 
With the pandemic still ongoing, costs of childbirth may yet still go up for all pregnant women, with 
some experts already proposing the need for universal testing of pregnant women for COVID-19 and 
a lower threshold for admitting pregnant women to hospital and intensive care unit.[24,25] This and 
any other additional costs may cause pregnant women to delay care-seeking, putting them at a 
greater risk of otherwise preventable obstetric complications. As these costs still need to be paid, 
the pandemic provides an opportunity to drive advocacy for enrolment in health insurance schemes. 
There are limitations to bear in mind in interpreting findings of this study. First, we did not collect 
household costs data in the pre-COVID era. Second, we only reported cost from one public tertiary 
hospital, and this cost may not be representative of the cost being incurred by women around the 
country, especially within the private sector, where costs for using services are typically higher than 
in the public sector.[12] Followup studies should be conducted to capture utilization costs for using 
other public and private facilities. 
In concluding, cost of utilizing maternity services for childbirth have increased and are likely to 
remain significantly high for women if exemptions being offered by governments become 
unaffordable, donations reduce or new requirements for universal testing have a chargeable fee. If 
COVID-19 becomes the new normal, then there will be many more pregnant women with COVID-19, 
including many who cannot afford the huge costs of care. Urgent measures are needed to ensure 
that women and their families are not being locked out of the health system. 
Author contributions 
AB-T conceived the study. AB-T and CAA led the study design. CCM, BBA and TAAN collected the 
data. AB-T and CCM conducted the data analysis. AB-T, CCM, MB, BBA and CAA were involved in 
drafting the manuscript. All authors read and approved the final version of the manuscript. 
Acknowledgements 
We are indebted to all the staff of the Lagos University Teaching Hospital who made data collection 
for this study possible and would like to particularly acknowledge the support of Pharmacist Olabisi 
Opanuga. We are especially grateful to the pregnant women with COVID-19 who took out time post-
discharge to take part in this study. 
Conflicts of interest 
The authors have no conflict of interest. 
 
References 
WHO. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. 2020 [cited 2020 Oct 12]. 
Available from: https://covid19.who.int/ 2. WHO, UNICEF, UNFPA, World Bank Group, UNDP. Trends 
in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the 
United Nations Population Division [Internet]. Geneva: World Health Organization; 2019. 1–119 p. 
Available from: https://www.unfpa.org/sites/default/files/pub-pdf/Maternal_mortality_report.pdf 
3. Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, et al. Early estimates of the 
indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and 
middle-income countries: a modelling study. Lancet Glob Heal. 2020;8(7):e901–8. 4. United Nations. 
Sustainable Development Goals: 17 goals to transform our world [Internet]. Sustainable 
Development Goals. 2016 [cited 2020 Oct 12]. Available from: 
http://www.un.org/sustainabledevelopment/sustainable-development-goals/ 5. Paxton A, Maine D, 
Freedman L. The evidence for emergency obstetric care. Int J Gynaecol Obstet. 2005;88:181–93. 6. 
Bailey P, van Roosmalen J, Mola G, Evans C, de Bernis L, Dao B. Assisted vaginal delivery in low and 
middle income countries: an overview. BJOG An Int J Obstet Gynaecol. 2017;124(9):1335–44. 7. 
Okunade KS, Makwe CC, Akinajo OR, Owie E, Ohazurike EO, Babah OA, et al. Good clinical practice 
advice for the management of pregnant women with suspected or confirmed COVID‐ 19 in Nigeria. 
Int J Gynecol Obstet. 2020;150(3):278–84. 8. NCDC. Confirmed Cases by State [Internet]. Abuja; 
2020. Available from: https://covid19.ncdc.gov.ng/ 9. OANDA. Currency Converter [Internet]. 
Currency Tools. 2020 [cited 2020 Aug 27]. Available from: 
https://www.oanda.com/currency/converter/ 10. WHO, UNFPA, UNICEF, Averting Maternal Deaths 
and Disabilities. Monitoring emergency obstetric care: a handbook. Geneva, Switzerland: WHO 
Press; 2009. 11. NCDC. National Interim Guidelines for Clinical Management of COVID-19 [Internet]. 
Abuja; 2020. Available from: 
https://ncdc.gov.ng/themes/common/docs/protocols/177_1584210847.pdf 12. Banke-Thomas A, 
Ayomoh FI, Abejirinde I-OO, Banke-Thomas O, Eboreime EA, Ameh CA. Cost of Utilising Maternal 
Health Services in Low- and MiddleIncome Countries: A Systematic Review. Int J Heal Policy Manag 
[Internet]. 2020;1–14. Available from: 10.34172/ijhpm.2020.104 13. Adamu AN, Adamu H, Isa A., 
Zubairu S. Expenditure on Emergency Obstetric Care in a Federal Tertiary Institution in Nigeria. J 
Women’s Heal Care. 2013;2(4):1000134. 14. Alagboso C, Abubakar B. The first 90 days: How has 
Nigeria responded to the COVID-19 outbreak? #COVID19NaijaResponse [Internet]. Medium. 2020 
[cited 2020 Aug 28]. Available from: https://medium.com/@nigeriahealthwatch/the-first-90-days-
how-has-nigeriaresponded-to-the-covid-19-outbreak-covid19naijaresponse-a0974493efa6 15. 
Naeche N. LUTH Receives PPE Equipment from SUNU Group. Business Today [Internet]. 2020 May 
[cited 2020 Sep 29]; Available from: https://businesstodayng.com/luth-receives-ppe-equipment-
from-sunu-group/ 16. Stein F, Perry M, Banda G, Woolhouse M, Mutapi F. Oxygen provision to fight 
COVID-19 in sub-Saharan Africa. Vol. 5, BMJ Global Health. 2020. p. 2786. 17. Kruk ME, Mbaruku G, 
Rockers PC, Galea S. User fee exemptions are not enough: out-of-pocket payments for ‘free’ delivery 
services in rural Tanzania. Trop Med Int Heal. 2008;13(12):1442–51. 18. Afsana K. The Tremendous 
Cost of Seeking Hospital Obstetric Care in Bangladesh. Reprod Health Matters. 2004;12(24):171–80. 
19. Semaan A, Audet C, Huysmans E, Afolabi B, Assarag B, Banke-Thomas A, et al. Voices from the 
frontline: findings from a thematic analysis of a rapid online global survey of maternal and newborn 
health professionals facing the COVID19 pandemic. BMJ Glob Heal. 2020;5(6):e002967. 20. Green L, 
Fateen D, Gupta D, McHale T, Nelson T, Mishori R. Providing women’s health care during COVID‐ 19: 
Personal and professional challenges faced by health workers. Int J Gynecol Obstet. 2020;151(1):3–6. 
21. Varrella S. Poverty headcount rate in Nigeria 2019, by state [Internet]. Statista. 2020 [cited 2020 
Sep 2]. Available from: https://www.statista.com/statistics/1121438/poverty-headcount-rate-in-
nigeriaby-state/ 22. James S. Lagos Takes up Medical Bills of Pregnant Women, Patients. ThisDay 
Newspaper [Internet]. 2020 Apr; Available from: 
https://www.thisdaylive.com/index.php/2020/04/05/lagos-takes-up-medicalbills-of-pregnant-
women-patients/ 23. Adediran I. Lagos defends spending about N1 million daily on severe COVID19 
cases, provides details. Premium Times [Internet]. 2020 Jul; Available from: 
https://www.premiumtimesng.com/news/headlines/404941-lagos-defendsspending-about-n1-
million-daily-on-severe-covid-19-cases-providesdetails.html 24. Silveira Campos L, Caldas JMP. 
Increasing maternal mortality associated with COVID‐ 19 and shortage of intensive care is a serious 
concern in low resource settings. Acta Obstet Gynecol Scand. 2020;99(10):1421. 25. Breslin N, 
Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. Coronavirus disease 2019 
infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed 
presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol. 
2020;2(2):100118. 
 
 
 
 
 
